R. Aderjan

744 total citations
53 papers, 529 citations indexed

About

R. Aderjan is a scholar working on Toxicology, Emergency Medicine and Pharmacology. According to data from OpenAlex, R. Aderjan has authored 53 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Toxicology, 13 papers in Emergency Medicine and 9 papers in Pharmacology. Recurrent topics in R. Aderjan's work include Forensic Toxicology and Drug Analysis (17 papers), Poisoning and overdose treatments (13 papers) and Alcohol Consumption and Health Effects (9 papers). R. Aderjan is often cited by papers focused on Forensic Toxicology and Drug Analysis (17 papers), Poisoning and overdose treatments (13 papers) and Alcohol Consumption and Health Effects (9 papers). R. Aderjan collaborates with scholars based in Germany, Austria and Netherlands. R. Aderjan's co-authors include Gisela Skopp, Georg Schmitt, R. Mattern, Lucia Pötsch, Holger Zimmer, Klaus Klinder, Munehiro Katagi, H. J. Buhr, Akihiro Miki and Th. Keller and has published in prestigious journals such as The Journal of Chemical Physics, Analytical and Bioanalytical Chemistry and European Journal of Endocrinology.

In The Last Decade

R. Aderjan

50 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Aderjan Germany 12 230 184 106 93 86 53 529
Hilke Andresen Germany 6 177 0.8× 110 0.6× 115 1.1× 131 1.4× 54 0.6× 9 697
Volker Auwaerter Germany 9 191 0.8× 271 1.5× 129 1.2× 66 0.7× 34 0.4× 12 519
Stéphane Pirnay France 16 255 1.1× 58 0.3× 83 0.8× 91 1.0× 84 1.0× 31 754
Ronald C. Backer United States 13 209 0.9× 32 0.2× 89 0.8× 102 1.1× 69 0.8× 32 483
Niclas Nikolai Stephanson Sweden 11 248 1.1× 116 0.6× 102 1.0× 37 0.4× 147 1.7× 15 528
Arthur J. McBay United States 16 182 0.8× 56 0.3× 48 0.5× 133 1.4× 61 0.7× 40 633
R. H. Cravey United States 13 139 0.6× 38 0.2× 51 0.5× 119 1.3× 78 0.9× 23 415
Marie L. Syrjanen Australia 10 133 0.6× 40 0.2× 45 0.4× 84 0.9× 51 0.6× 12 438
Anne Smith‐Kielland Norway 14 202 0.9× 163 0.9× 98 0.9× 47 0.5× 21 0.2× 25 549
Claudia Vignali Italy 18 529 2.3× 113 0.6× 132 1.2× 90 1.0× 160 1.9× 49 783

Countries citing papers authored by R. Aderjan

Since Specialization
Citations

This map shows the geographic impact of R. Aderjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Aderjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Aderjan more than expected).

Fields of papers citing papers by R. Aderjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Aderjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Aderjan. The network helps show where R. Aderjan may publish in the future.

Co-authorship network of co-authors of R. Aderjan

This figure shows the co-authorship network connecting the top 25 collaborators of R. Aderjan. A scholar is included among the top collaborators of R. Aderjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Aderjan. R. Aderjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skopp, Gisela, R. Aderjan, & Jenne De Koster. (2008). Haaranalyse zur Diagnose toxischer Hepatitiden nach Mißbrauch von »Ecstacy«. DMW - Deutsche Medizinische Wochenschrift. 120(34/35). 1165–1168. 1 indexed citations
2.
Henrion, André, et al.. (2008). Reference measurement procedure for Δ9-tetrahydrocannabinol in serum. Analytical and Bioanalytical Chemistry. 391(3). 1003–1010. 2 indexed citations
3.
Schulz, Karl‐Heinz, et al.. (2006). Inventory of Congener Analysis and Results of First Proficiency Tests. 43(4). 269–276. 2 indexed citations
4.
Schmidt, Harald, Stefan Viktor Vormfelde, Klaus Klinder, et al.. (2003). The role of active metabolites in dihydrocodeine effects. International Journal of Clinical Pharmacology and Therapeutics. 41(3). 95–106. 30 indexed citations
5.
Aderjan, R., et al.. (2003). Empfehlung der Kommission "Grenzwertfragen bei Arzneimitteln und Suchtstoffen" zum Nachweis von Betaeubungsmitteln im Blut. Immunologische Messungen von Substanzen im Blut reichen fuer den Nachweis einer Ordnungswidrigkeit im Sinne des Paragrafen 24a Absatz 2 StVG nicht aus / Recommendation of the committee "Questions of threshold values for medical and addictive drugs" for proving narcotics in blood. Immunological measurements of substances in blood do not suffice as proof for a law …. 40(5). 1 indexed citations
6.
Skopp, Gisela, Lucia Pötsch, Klaus Klinder, et al.. (2001). Saliva testing after single and chronic administration of dihydrocodeine. International Journal of Legal Medicine. 114(3). 133–140. 12 indexed citations
7.
8.
9.
Skopp, Gisela, et al.. (2000). GC/MS-determination of THCCOOH in serum: Comparison of different processing methods and the influence of THCCOOHglucuronid. 37(1). 48–56. 10 indexed citations
10.
Nishikawa, Mayumi, Hitoshi Tsuchihashi, Akihiro Miki, et al.. (1999). Determination of ethyl glucuronide, a minor metabolite of ethanol, in human serum by liquid chromatography–electrospray ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 726(1-2). 105–110. 51 indexed citations
11.
Skopp, Gisela, et al.. (1999). Freie und glucuronidierte Cannabinoide im Urin - Untersuchungen zur Einschätzung des Konsumverhaltens. Rechtsmedizin. 10(1). 21–28. 21 indexed citations
12.
Skopp, Gisela, Rainer Lutz, Lucia Pötsch, et al.. (1997). An In Vitro Experiment for Postmortem Vascular Permeation. The Passage of Morphine and Morphine Glucuronides Across a Vascular Wall. Journal of Forensic Sciences. 42(3). 486–491. 6 indexed citations
13.
Skopp, Gisela, et al.. (1996). Postmortem distribution pattern of morphine and morphine glucuronides in heroin overdose. International Journal of Legal Medicine. 109(3). 118–124. 37 indexed citations
14.
Schmitt, Georg, M Bogusz, R. Aderjan, & Christine Meyer. (1990). Zum Nachweis von Morphin und Codein in Blutproben mit GC/MS (NCI und PCI) und zur Unterscheidung einer Codeinaufnahme von Heroino- der Morphinkonsum. International Journal of Legal Medicine. 103(7). 513–521. 2 indexed citations
15.
Aderjan, R., et al.. (1989). PROGRAMMIERUNG UND STRUKTUR EINES RELATIONALEN DATENBANKSYSTEMS FUER REGISTRATUR, BLUTALKOHOLBEFUNDUNG UND BEFUNDDOKUMENTATION AM INSTITUT FUER RECHTSMEDIZIN DER UNIVERSITAET HEIDELBERG. 1 indexed citations
16.
Aderjan, R., et al.. (1988). Chemisch-Toxikologische Befunde bei einer t�dlich verlaufenen suicidalen Vergiftung mit Demeton-S-Methyl. International Journal of Legal Medicine. 101(1). 55–60. 2 indexed citations
17.
Bogusz, M, R. Aderjan, Jan Piet Franke, & Dick de Zeeuw. (1987). Instrumental set-up as a factor influencing the variability of retention index values in high pressure liquid chromatography. International Journal of Legal Medicine. 98(4). 263–8. 9 indexed citations
18.
Fechner, G., et al.. (1986). Tdliche vergiftung mit protriptylin und haloperidol nach extremer berdosierung@@@Lethal toxification with protriptyline and haloperidol after massive overdose. 97(4). 1 indexed citations
19.
Aderjan, R. & R. Mattern. (1980). Zur Wertigkeit postmortaler Digoxin-Konzentrationen im Blut. International Journal of Legal Medicine. 86(1). 13–20. 14 indexed citations
20.
Will, Hans, R. Aderjan, Th. Winkler, Botond Penke, & P. Vecsei. (1977). RADIOIMMUNOASSAYS OF TETRAHYDROCORTISONE AND TETRAHYDROCORTISOL IN HUMAN URINE. European Journal of Endocrinology. 86(2). 369–379. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilke Andresen Breakdown of academic impact, for papers by Volker Auwaerter Breakdown of academic impact, for papers by Stéphane Pirnay Breakdown of academic impact, for papers by Ronald C. Backer Breakdown of academic impact, for papers by Niclas Nikolai Stephanson Breakdown of academic impact, for papers by Arthur J. McBay Breakdown of academic impact, for papers by R. H. Cravey Breakdown of academic impact, for papers by Marie L. Syrjanen Breakdown of academic impact, for papers by Anne Smith‐Kielland Breakdown of academic impact, for papers by Claudia Vignali
Rankless by CCL
2026